{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:35:16Z","timestamp":1780965316112,"version":"3.54.1"},"reference-count":44,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["RRCT"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>Prolactinomas are the most common type of pituitary gland tumors that\nsecrete overly prolactin. They account for approximately 60% of all hormone-secreting hypophysis\ntumors.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Aim:<\/jats:title>\n<jats:p>This study aims to analyze gender differences in patients with prolactinomas who were operated\non transsphenoidal surgery and conduct a single-center retrospective analysis of patient data.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Material and Methods:<\/jats:title>\n<jats:p>This study evaluated the medical records of 109 patients (61 females and\n48 males) from 2009 to 2019 at Feofaniya Clinical Hospital of the State Administration of Affairs\nin Kyiv, Ukraine. The primary criterion for including patients was a Serum Prolactin (PRL) level\nof over 100 ng\/ml and the presence of a pituitary adenoma (PA) as observed on MRI. Additionally,\nthe histological examination needed to confirm the presence of Prolactin-Secreting Pituitary\nAdenomas (PSPAs) without plurihormonal activity through both microscopy and immunohistochemical\n(IHC) staining.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Significant differences in preoperative PRL levels were not observed. However, males\nhad significantly larger tumor sizes and prevalence of macroadenomas. In male patients, the preoperative\nPLR levels showed a weak negative correlation with age (r=-0.304, p &lt; 0.036) and a positive\ncorrelation with tumor size (r=0.555, p &lt; 0.001) and cavernous sinus invasion (r=0.339, p &lt; 0.018). In females, preoperative PRL was significantly associated only with tumor size and Knosp\ngrade.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Prolactin-Secreting Pituitary Adenomas (PSPAs) are more common in women than\nmen and are characterized by larger and more invasive tumors with high PRL levels at diagnosis.\nThe PRL level and tumor size before surgery can predict early biochemical remission in both\nmales and females with an accuracy of 58.3% and 68.8%, respectively.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115748871288948240325080936","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T03:27:14Z","timestamp":1712028434000},"page":"204-214","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Gender Differences in Patients with Prolactinoma: Single-center\nUkrainian Experience"],"prefix":"10.2174","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8254-9811","authenticated-orcid":true,"given":"Oleksandr","family":"Voznyak","sequence":"first","affiliation":[{"name":"Centre of Neurosurgery, Clinical Hospital &#34;Feofaniya&#34;, Zabolotny str, 21, Kyiv, 03143, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iaroslav","family":"Zinkevych","sequence":"additional","affiliation":[{"name":"Centre of Neurosurgery, Clinical Hospital &#34;Feofaniya&#34;, Zabolotny str, 21, Kyiv, 03143, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrii","family":"Lytvynenko","sequence":"additional","affiliation":[{"name":"Centre of Neurosurgery, Clinical Hospital &#34;Feofaniya&#34;, Zabolotny str, 21, Kyiv, 03143, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4423-9922","authenticated-orcid":true,"given":"Nazarii","family":"Hryniv","sequence":"additional","affiliation":[{"name":"Centre of Neurosurgery, Clinical Hospital &#34;Feofaniya&#34;, Zabolotny str, 21, Kyiv, 03143, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Ilyuk","sequence":"additional","affiliation":[{"name":"Centre of Neurosurgery, Clinical Hospital &#34;Feofaniya&#34;, Zabolotny str, 21, Kyiv, 03143, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9814-689X","authenticated-orcid":true,"given":"Nazarii","family":"Kobyliak","sequence":"additional","affiliation":[{"name":"Medical Laboratory\nCSD, Kyiv, 02000, Ukraine"},{"name":"Department of Endocrinology, Bogomolets National Medical University, Kyiv, 01024,\nUkraine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"101290","DOI":"10.1016\/j.beem.2019.101290","volume":"33","author":"Chanson P.","year":"2019","unstructured":"Chanson P.; Maiter D.; The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new. Best Pract Res Clin Endocrinol Metab  2019,33(2),101290","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11102-005-5079-0","volume":"8","author":"Ciccarelli A.","year":"2005","unstructured":"Ciccarelli A.; Daly A.F.; Beckers A.; The epidemiology of prolactinomas. Pituitary  2005,8(1),3-6","journal-title":"Pituitary"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3389\/fendo.2020.00439","volume":"11","author":"Zielinski G.","year":"2020","unstructured":"Zielinski G.; Ozdarski M.; Maksymowicz M.; Szamotulska K.; Witek P.; Prolactinomas: Prognostic factors of early remission after transsphenoidal surgery. Front Endocrinol  2020,11,439","journal-title":"Front Endocrinol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.beem.2009.05.008","volume":"23","author":"Daly A.F.","year":"2009","unstructured":"Daly A.F.; Tichomirowa M.A.; Beckers A.; The epidemiology and genetics of pituitary adenomas. Best Pract Res Clin Endocrinol Metab  2009,23(5),543-554","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.beem.2009.05.001","volume":"23","author":"Molitch M.E.","year":"2009","unstructured":"Molitch M.E.; Pituitary incidentalomas. Best Pract Res Clin Endocrinol Metab  2009,23(5),667-675","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/er.2005-9998","volume":"27","author":"Gillam M.P.","year":"2006","unstructured":"Gillam M.P.; Molitch M.E.; Lombardi G.; Colao A.; Advances in the treatment of prolactinomas. Endocr Rev  2006,27(5),485-534","journal-title":"Endocr Rev"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1283179","DOI":"10.3389\/fsurg.2024.1283179","volume":"11","author":"Voznyak O.","year":"2024","unstructured":"Voznyak O.; Zinkevych I.; Lytvynenko A.; Hryniv N.; Ilyuk R.; Kobyliak N.; Prognostic factors for surgical treatment of prolactin-secreting pituitary adenomas. Front Surg  2024,11,1283179","journal-title":"Front Surg"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1055\/s-0037-1615748","volume":"79","author":"Yoo F.","year":"2018","unstructured":"Yoo F.; Chan C.; Kuan E.; Bergsneider M.; Wang M.; Comparison of male and female prolactinoma patients requiring surgical intervention. J Neurol Surg B Skull Base  2018,79(4),394-400","journal-title":"J Neurol Surg B Skull Base"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","volume":"43","author":"Melmed S.","year":"2022","unstructured":"Melmed S.; Kaiser U.B.; Lopes M.B.; Bertherat J.; Syro L.V.; Raverot G.; Reincke M.; Johannsson G.; Beckers A.; Fleseriu M.; Giustina A.; Wass J.A.H.; Ho K.K.Y.; Clinical biology of the pituitary adenoma. Endocr Rev  2022,43(6),1003-1037","journal-title":"Endocr Rev"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00701-005-0498-2","volume":"147","author":"Delgrange E.","year":"2005","unstructured":"Delgrange E.; Sassolas G.; Perrin G.; Jan M.; Trouillas J.; Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance. Acta Neurochir  2005,147(7),751-758","journal-title":"Acta Neurochir"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ando.2020.12.008","volume":"82","author":"Castinetti F.","year":"2021","unstructured":"Castinetti F.; Albarel F.; Amodru V.; Cuny T.; Dufour H.; Graillon T.; Morange I.; Brue T.; The risks of medical treatment of prolactinoma. Ann Endocrinol  2021,82(1),15-19","journal-title":"Ann Endocrinol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/9930059","volume":"2021","author":"Lu J.","year":"2021","unstructured":"Lu J.; Cai L.; Wu Z.; Lin W.; Xu J.; Zhu Z.; Wang C.; Li Q.; Su Z.; Surgery and medical treatment in microprolactinoma: A systematic review and meta-analysis. Int J Endocrinol  2021,2021,1-11","journal-title":"Int J Endocrinol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3390\/medicina58081095","volume":"58","author":"Inder W.J.","year":"2022","unstructured":"Inder W.J.; Jang C.; Treatment of prolactinoma. Medicina  2022,58(8),1095","journal-title":"Medicina"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJM199410063311403","volume":"331","author":"Webster J.","year":"1994","unstructured":"Webster J.; Piscitelli G.; Polli A.; Ferrari C.I.; Ismail I.; Scanlon M.F.; A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N Engl J Med  1994,331(14),904-909","journal-title":"N Engl J Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.3390\/cancers14153604","volume":"14","author":"Fukuhara N.","year":"2022","unstructured":"Fukuhara N.; Nishiyama M.; Iwasaki Y.; Update in pathogenesis, diagnosis, and therapy of prolactinoma. Cancers  2022,14(15),3604","journal-title":"Cancers"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.otc.2021.12.005","volume":"55","author":"Haider S.A.","year":"2022","unstructured":"Haider S.A.; Levy S.; Rock J.P.; Craig J.R.; Prolactinoma. Otolaryngol Clin North Am  2022,55(2),305-314","journal-title":"Otolaryngol Clin North Am"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1056\/NEJMra1810772","volume":"382","author":"Melmed S.","year":"2020","unstructured":"Melmed S.; Pituitary-tumor endocrinopathies. N Engl J Med  2020,382(10),937-950","journal-title":"N Engl J Med"},{"key":"ref=18","first-page":"450","volume":"10","author":"Jackman S.","year":"2013","unstructured":"Jackman S.; Diamond F.; Pituitary adenomas in childhood and adolescence. Pediatr Endocrinol Rev  2013,10(4),450-459","journal-title":"Pediatr Endocrinol Rev"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000236081","volume":"72","author":"Fideleff H.L.","year":"2009","unstructured":"Fideleff H.L.; Boquete H.R.; Su\u00e1rez M.G.; Azaretzky M.; Prolactinoma in children and adolescents. Horm Res Paediatr  2009,72(4),197-205","journal-title":"Horm Res Paediatr"},{"key":"ref=20","first-page":"152","volume":"26","author":"Schaller B.","year":"2005","unstructured":"Schaller B.; Gender-related differences in prolactinomas. A clinicopathological study. Neuroendocrinol Lett  2005,26(2),152-159","journal-title":"Neuroendocrinol Lett"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00234-002-0774-2","volume":"44","author":"Nishioka H.","year":"2002","unstructured":"Nishioka H.; Haraoka J.; Akada K.; Azuma S.; Gender-related differences in prolactin secretion in pituitary prolactinomas. Neuroradiology  2002,44(5),407-410","journal-title":"Neuroradiology"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1227\/00006123-199310000-00008","volume":"33","author":"Knosp E.","year":"1993","unstructured":"Knosp E.; Steiner E.; Kitz K.; Matula C.; Pituitary adenomas with invasion of the cavernous sinus space: A magnetic resonance imaging classification compared with surgical findings. Neurosurgery  1993,33(4),610-618","journal-title":"Neurosurgery"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s11102-022-01221-3","volume":"25","author":"Abou-Al-Shaar H.","year":"2022","unstructured":"Abou-Al-Shaar H.; Mallela A.N.; Patel A.; Shariff R.K.; Shin S.S.; Choi P.A.; Faraji A.H.; Fazeli P.K.; Costacou T.; Wang E.W.; Fernandez-Miranda J.C.; Snyderman C.H.; Gardner P.A.; Zenonos G.A.; The role of endoscopic endonasal surgery in the management of prolactinomas based on their invasiveness into the cavernous sinus. Pituitary  2022,25(3),508-519","journal-title":"Pituitary"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3171\/jns.2002.97.2.0307","volume":"97","author":"Amar A.P.","year":"2002","unstructured":"Amar A.P.; Couldwell W.T.; Chen J.C.T.; Weiss M.H.; Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery. J Neurosurg  2002,97(2),307-314","journal-title":"J Neurosurg"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","volume":"134","author":"Lopes M.B.S.","year":"2017","unstructured":"Lopes M.B.S.; The 2017 world health organization classification of tumors of the pituitary gland: A summary. Acta Neuropathol  2017,134(4),521-535","journal-title":"Acta Neuropathol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40200-015-0170-1","volume":"14","author":"Mykhalchyshyn G.","year":"2015","unstructured":"Mykhalchyshyn G.; Kobyliak N.; Bodnar P.; Diagnostic accuracy of acyl-ghrelin and it association with non-alcoholic fatty liver disease in type 2 diabetic patients. J Diabetes Metab Disord  2015,14(1),44","journal-title":"J Diabetes Metab Disord"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.clineuro.2018.11.024","volume":"176","author":"Lamba N.","year":"2019","unstructured":"Lamba N.; Noormohamed N.; Simjian T.; Alsheikh M.Y.; Jamal A.; Doucette J.; Zaidi H.; Smith T.R.; Mekary R.A.; Fertility after transsphenoidal surgery in patients with prolactinomas: A meta-analysis. Clin Neurol Neurosurg  2019,176,53-60","journal-title":"Clin Neurol Neurosurg"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.jocn.2015.03.058","volume":"22","author":"Wong A.","year":"2015","unstructured":"Wong A.; Eloy J.A.; Couldwell W.T.; Liu J.K.; Update on prolactinomas. Part 1: Clinical manifestations and diagnostic challenges. J Clin Neurosci  2015,22(10),1562-1567","journal-title":"J Clin Neurosci"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1365-2265.2005.02364.x","volume":"63","author":"Berinder K.","year":"2005","unstructured":"Berinder K.; Stacken\u00e4s I.; Akre O.; Hirschberg A.L.; Hulting A.L.; Hyperprolactinaemia in 271 women: Up to three decades of clinical follow-up. Clin Endocrinol (Oxf)  2005,63(4),450-455","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ajog.2011.12.010","volume":"206","author":"Lee DY","year":"2012","unstructured":"Lee DY; Oh YK; Yoon BK; Choi D; Prevalence of hyperprolactinemia in adolescents and young women with menstruation-related problems. Am J Obstet Gynecol  2012,206,213","journal-title":"Am J Obstet Gynecol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.fertnstert.2009.12.017","volume":"94","author":"Souter I.","year":"2010","unstructured":"Souter I.; Baltagi L.M.; Toth T.L.; Petrozza J.C.; Prevalence of hyperprolactinemia and abnormal magnetic resonance imaging findings in a population with infertility. Fertil Steril  2010,94(3),1159-1162","journal-title":"Fertil Steril"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1365-2265.2006.02493.x","volume":"64","author":"Delgrange E.","year":"2006","unstructured":"Delgrange E.; Duprez T.; Maiter D.; Influence of parasellar extension of macroprolactinomas defined by magnetic resonance imaging on their responsiveness to dopamine agonist therapy. Clin Endocrinol  2006,64(4),456-462","journal-title":"Clin Endocrinol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1172\/JCI63937","volume":"122","author":"Sonigo C.","year":"2012","unstructured":"Sonigo C.; Bouilly J.; Carr\u00e9 N.; Tolle V.; Caraty A.; Tello J.; Simony-Conesa F.J.; Millar R.; Young J.; Binart N.; Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration. J Clin Invest  2012,122(10),3791-3795","journal-title":"J Clin Invest"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1210\/js.2017-00328","volume":"1","author":"Millar R.P.","year":"2017","unstructured":"Millar R.P.; Sonigo C.; Anderson R.A.; George J.; Maione L.; Brailly-Tabard S.; Chanson P.; Binart N.; Young J.; Hypothalamic-pituitary-ovarian axis reactivation by kisspeptin-10 in hyperprolactinemic women with chronic amenorrhea. J Endocr Soc  2017,1(11),1362-1371","journal-title":"J Endocr Soc"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12020-014-0259-1","volume":"47","author":"Shimon I.","year":"2014","unstructured":"Shimon I.; Bronstein M.D.; Shapiro J.; Tsvetov G.; Benbassat C.; Barkan A.; Women with prolactinomas presented at the postmenopausal period. Endocrine  2014,47(3),889-894","journal-title":"Endocrine"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/cen.13399","volume":"87","author":"Santharam S.","year":"2017","unstructured":"Santharam S.; Tampourlou M.; Arlt W.; Ayuk J.; Gittoes N.; Toogood A.; Webster R.; Karavitaki N.; Prolactinomas diagnosed in the postmenopausal period: Clinical phenotype and outcomes. Clin Endocrinol  2017,87(5),508-514","journal-title":"Clin Endocrinol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000494725","volume":"109","author":"Peki\u0107 S.","year":"2019","unstructured":"Peki\u0107 S.; Medic Stojanoska M.; Popovic V.; Hyperprolactinemia\/prolactinomas in the postmenopausal period: Challenges in diagnosis and management. Neuroendocrinology  2019,109(1),28-33","journal-title":"Neuroendocrinology"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S0090-3019(03)00012-0","volume":"59","author":"Nishioka H.","year":"2003","unstructured":"Nishioka H.; Haraoka J.; Akada K.; Growth potential of prolactinomas in men: Is it really different from women? Surg Neurol  2003,59(5),386-390","journal-title":"Surg Neurol"},{"key":"ref=39","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-11836-5","author":"Tritos N.A.","year":"2019","unstructured":"Tritos N.A.; Klibanski A.;  Eds Prolactin Disorders  2019","journal-title":"Eds Prolactin Disorders"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000499382","volume":"109","author":"Trouillas J.","year":"2019","unstructured":"Trouillas J.; Delgrange E.; Wierinckx A.; Vasiljevic A.; Jouanneau E.; Burman P.; Raverot G.; Clinical, pathological, and molecular factors of aggressiveness in lactotroph tumours. Neuroendocrinology  2019,109(1),70-76","journal-title":"Neuroendocrinology"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3389\/fendo.2018.00706","volume":"9","author":"Wierinckx A.","year":"2018","unstructured":"Wierinckx A.; Delgrange E.; Bertolino P.; Fran\u00e7ois P.; Chanson P.; Jouanneau E.; Lachuer J.; Trouillas J.; Raverot G.; Sex-related differences in lactotroph tumor aggressiveness are associated with a specific gene-expression signature and genome instability. Front Endocrinol  2018,9,706","journal-title":"Front Endocrinol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1210\/jcem.82.7.4088","volume":"82","author":"Delgrange E.","year":"1997","unstructured":"Delgrange E.; Trouillas J.; Maiter D.; Sex-related difference in the growth of prolactinomas: A clinical and proliferation marker study 1. J Clin Endocrinol Metab  1997,82,2102-2107","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0090-3019(01)00407-4","volume":"55","author":"Nishioka H.","year":"2001","unstructured":"Nishioka H.; Ito H.; Haraoka J.; Hirano A.; Growth potential of female prolactinomas. Surg Neurol  2001,55(4),213-217","journal-title":"Surg Neurol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0889-8529(05)70061-X","volume":"28","author":"Molitch ME","year":"1999","unstructured":"Molitch ME; Medical treatment of prolactinomas. Endocrinol Metab Clin N Am  1999,28,143-169","journal-title":"Endocrinol Metab Clin N Am"}],"container-title":["Reviews on Recent Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115748871288948240325080936","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/228484\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115748871288948240325080936","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T06:26:41Z","timestamp":1726813601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/228484\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115748871288948240325080936","relation":{},"ISSN":["1574-8871"],"issn-type":[{"value":"1574-8871","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-12-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}